|
Other lipid modifying agents
|
C10AX |
|
|
streptokinase
|
B01AD01 |
|
|
TETRACYCLINES
|
J01A |
|
|
diiodohydroxypropane
|
D08AG04 |
|
|
AMPHENICOLS
|
J01B |
|
|
bisacodyl, combinations
|
A06AB52 |
|
|
bisoprolol and acetylsalicylic acid
|
C07FX04 |
|
|
metoprolol and ivabradine
|
C07FX05 |
|
|
carvedilol and ivabradine
|
C07FX06 |
|
|
iodine/octylphenoxypolyglycolether
|
D08AG01 |
|
|
Androstan derivatives
|
A14AA |
|
|
propranolol and other combinations
|
C07FX01 |
|
|
Estren derivatives
|
A14AB |
|
|
HMG CoA reductase inhibitors in combination with other lipid modifying agents
|
C10BA |
|
|
sotalol and acetylsalicylic acid
|
C07FX02 |
|
|
metoprolol and acetylsalicylic acid
|
C07FX03 |
|
|
Dichloroacetamide derivatives
|
P01AC |
|
|
Nitroimidazole derivatives
|
P01AB |
|
|
Hydroxyquinoline derivatives
|
P01AA |
|
|
propanol
|
D08AX03 |
|
